GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) » Definitions » Total Equity

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Total Equity : ¥3,190 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zhejiang Huakang Pharmaceutical Co Total Equity?

Zhejiang Huakang Pharmaceutical Co's total equity for the quarter that ended in Mar. 2024 was ¥3,190 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Zhejiang Huakang Pharmaceutical Co Total Equity Historical Data

The historical data trend for Zhejiang Huakang Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huakang Pharmaceutical Co Total Equity Chart

Zhejiang Huakang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 684.81 939.52 2,434.44 2,655.81 3,101.02

Zhejiang Huakang Pharmaceutical Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,756.45 2,714.63 2,804.58 3,101.02 3,189.96

Zhejiang Huakang Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zhejiang Huakang Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=6177.682-3076.662
=3,101

Zhejiang Huakang Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=6271.911-3081.951
=3,190

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Huakang Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Zhejiang Huakang Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Huagong Road, Huabu Town, Zhejiang Province, Kaihua County, Quzhou, CHN, 324302
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
Executives
Du Yong Rui Director
Zheng Fang Ming senior management
Jiang Xue Song Supervisors
Yu Jian Ming Directors, senior managers
Chen De Shui Directors, senior managers
Xu Xiao Rong Director
Cheng Xin Ping Directors, senior managers
Yan Xiao Xing Supervisors
Cao Jian Hong Director

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Headlines

No Headlines